Optimization strategy for the early timing of bronchoalveolar lavage treatment for children with severe mycoplasma pneumoniae pneumonia.
Children
Kaplan–Meier analysis
Nomogram model
Severe mycoplasma pneumoniae pneumonia
Therapeutic bronchoalveolar lavage
Journal
BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551
Informations de publication
Date de publication:
05 Oct 2023
05 Oct 2023
Historique:
received:
07
07
2023
accepted:
18
09
2023
medline:
1
11
2023
pubmed:
6
10
2023
entrez:
5
10
2023
Statut:
epublish
Résumé
Early evaluation of severe mycoplasma pneumoniae pneumonia (SMPP) and the prompt utilization of fiberoptic bronchoscopic manipulation can effectively alleviate complications and restrict the progression of sequelae. This study aim to establish a nomogram forecasting model for SMPP in children and explore an optimal early therapeutic bronchoalveolar lavage (TBAL) treatment strategy. This retrospective study included children with mycoplasma pneumoniae pneumonia (MPP) from January 2019 to December 2021. Multivariate logistic regression analysis was used to screen independent risk factors for SMPP and establish a nomogram model. The bootstrap method was employed and a receiver operator characteristic (ROC) curve was drawn to evaluate the accuracy and robustness of the model. Kaplan-Meier analysis was used to assess the effect of lavage and hospitalization times. A total of 244 cases were enrolled in the study, among whom 68 with SMPP and 176 with non-SMPP (NSMPP). A prediction model with five independent risk factors: left upper lobe computed tomography (CT) score, sequential organ failure assessment (SOFA) score, acute physiology and chronic health assessment (APACHE) II score, bronchitis score (BS), and c-reactive protein (CRP) was established based on the multivariate logistic regression analysis. The ROC curve of the prediction model showed the area under ROC curve (AUC) was 0.985 (95% confidence interval (CI) 0.972-0.997). The Hosmer-Lemeshow goodness-of-fit test results showed that the nomogram model predicted the risk of SMPP well (χ2 = 2.127, P = 0.977). The log-rank result suggested that an early BAL treatment could shorten MPP hospitalization time (P = 0.0057). This nomogram model, based on the left upper lobe CT score, SOFA score, APACHE II score, BS, and CRP level, represents a valuable tool to predict the risk of SMPP in children and optimize the timing of TBAL.
Sections du résumé
BACKGROUND
BACKGROUND
Early evaluation of severe mycoplasma pneumoniae pneumonia (SMPP) and the prompt utilization of fiberoptic bronchoscopic manipulation can effectively alleviate complications and restrict the progression of sequelae. This study aim to establish a nomogram forecasting model for SMPP in children and explore an optimal early therapeutic bronchoalveolar lavage (TBAL) treatment strategy.
METHODS
METHODS
This retrospective study included children with mycoplasma pneumoniae pneumonia (MPP) from January 2019 to December 2021. Multivariate logistic regression analysis was used to screen independent risk factors for SMPP and establish a nomogram model. The bootstrap method was employed and a receiver operator characteristic (ROC) curve was drawn to evaluate the accuracy and robustness of the model. Kaplan-Meier analysis was used to assess the effect of lavage and hospitalization times.
RESULTS
RESULTS
A total of 244 cases were enrolled in the study, among whom 68 with SMPP and 176 with non-SMPP (NSMPP). A prediction model with five independent risk factors: left upper lobe computed tomography (CT) score, sequential organ failure assessment (SOFA) score, acute physiology and chronic health assessment (APACHE) II score, bronchitis score (BS), and c-reactive protein (CRP) was established based on the multivariate logistic regression analysis. The ROC curve of the prediction model showed the area under ROC curve (AUC) was 0.985 (95% confidence interval (CI) 0.972-0.997). The Hosmer-Lemeshow goodness-of-fit test results showed that the nomogram model predicted the risk of SMPP well (χ2 = 2.127, P = 0.977). The log-rank result suggested that an early BAL treatment could shorten MPP hospitalization time (P = 0.0057).
CONCLUSION
CONCLUSIONS
This nomogram model, based on the left upper lobe CT score, SOFA score, APACHE II score, BS, and CRP level, represents a valuable tool to predict the risk of SMPP in children and optimize the timing of TBAL.
Identifiants
pubmed: 37798699
doi: 10.1186/s12879-023-08619-9
pii: 10.1186/s12879-023-08619-9
pmc: PMC10557288
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
661Subventions
Organisme : Youth Fund Project of the First Affiliated Hospital of Xinxiang Medical University
ID : QN-2022-A05, QN-2022-A10
Informations de copyright
© 2023. BioMed Central Ltd., part of Springer Nature.
Références
Front Microbiol. 2016 Jun 01;7:800
pubmed: 27313568
Pediatr Res. 2023 Jan;93(1):198-206
pubmed: 35459766
Ital J Pediatr. 2023 Apr 7;49(1):44
pubmed: 37024936
J Pediatr (Rio J). 2020 Mar - Apr;96 Suppl 1:29-38
pubmed: 31518547
Bosn J Basic Med Sci. 2019 Aug 20;19(3):288-296
pubmed: 30878034
PLoS One. 2018 Apr 26;13(4):e0195288
pubmed: 29698412
Zhonghua Er Ke Za Zhi. 2015 Oct;53(10):779-83
pubmed: 26758116
Curr Microbiol. 2022 Dec 2;80(1):14
pubmed: 36459213
IUBMB Life. 2019 Feb;71(2):152-165
pubmed: 30466159
Eur J Pediatr. 2023 Mar;182(3):1239-1249
pubmed: 36633659
Zhonghua Er Ke Za Zhi. 2018 May 2;56(5):347-352
pubmed: 29783820
BMC Pulm Med. 2023 May 15;23(1):169
pubmed: 37189036
J Formos Med Assoc. 2021 Jan;120(1 Pt 1):281-291
pubmed: 32948415
Front Microbiol. 2016 Mar 23;7:329
pubmed: 27047456
AJR Am J Roentgenol. 2020 Aug;215(2):367-373
pubmed: 32223665
Clin Respir J. 2015 Jul;9(3):366-71
pubmed: 24720856
Front Surg. 2022 May 25;9:897550
pubmed: 35693303
Panminerva Med. 2021 Dec;63(4):529-538
pubmed: 34606187
Sci Rep. 2023 Mar 28;13(1):5084
pubmed: 36977721
Pediatr Infect Dis J. 2018 Dec;37(12):e336-e338
pubmed: 29912842
Front Pediatr. 2023 Jan 04;10:1066640
pubmed: 36683805
Medicine (Baltimore). 2019 Jun;98(26):e16204
pubmed: 31261567
Front Pediatr. 2023 Jan 06;10:925655
pubmed: 36683817
BMC Pulm Med. 2022 Jun 27;22(1):253
pubmed: 35761218
Pediatr Pulmonol. 2020 Sep;55(9):2444-2451
pubmed: 32584469
Genes (Basel). 2022 Aug 31;13(9):
pubmed: 36140733
Front Med (Lausanne). 2022 Jan 26;8:744907
pubmed: 35155461
Clin Infect Dis. 2019 Jan 1;68(1):5-12
pubmed: 29788037
Surg Today. 2022 Apr;52(4):550-558
pubmed: 35179645